Keytruda (pembrolizumab) is an immune checkpoint inhibitor that works by blocking the PD-1 receptor on T cells, enhancing the body's immune response against cancer cells.

Feb 1, 2022 · Immune checkpoint proteins dampen the immune response by inactivating immune cells capable of tumour destruction. Blockade of immune checkpoints has shown impressive …

Nov 14, 2025 · Perjeta (chemical name: pertuzumab) is a HER2 -inhibitor targeted therapy medication. If you’ve been diagnosed with metastatic, HER2-positive breast cancer and you …

Compare Keytruda and Perjeta to discover which is more effective, safer, and easier to use. Learn about their pros and cons, including side effects, addiction risks, and treatment options.

PERJETA can cause subclinical and clinical cardiac failure manifesting as decreased left ventricular ejection fraction (LVEF) and congestive heart failure (CHF). Evaluate cardiac …

May 23, 2025 · Perjeta is a cancer medication that interferes with the growth and spread of cancer cells in the body. Perjeta is used together with other cancer medicines (trastuzumab and …

Oct 30, 2025 · Perjeta is indicated for use in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of adult patients with HER2-positive, locally advanced, …

Perjeta is a medicine that targets the HER2 receptor, a protein found on the outside of many normal cells and in high quantities on the outside of cancer cells in HER2-positive cancers.

Pertuzumab works by locking onto HER2 on the cancer cells. It stops them from growing and kills them. Pertuzumab only works if your cancer is HER2 positive. How do you have pertuzumab? …

Sep 17, 2025 · HER2-positive tumors have a lot of the protein called HER2 on the surface of the cancer cells. The drugs pertuzumab (Perjeta) and trastuzumab (Herceptin) target HER2 …